OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Clinical and Virological Response to a Neutralizing Monoclonal Antibody for Hospitalized Patients with COVID-19
Jens Lundgren, Birgit Grund, Christina E. Barkauskas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Jens Lundgren, Birgit Grund, Christina E. Barkauskas, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 4
Showing 4 citing articles:
Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial
Wesley H. Self, Uriel Sandkovsky, Cavan Reilly, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 5, pp. 622-635
Open Access | Times Cited: 182
Wesley H. Self, Uriel Sandkovsky, Cavan Reilly, et al.
The Lancet Infectious Diseases (2021) Vol. 22, Iss. 5, pp. 622-635
Open Access | Times Cited: 182
Casirivimab and Imdevimab for the Treatment of Hospitalized Patients With COVID-19
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya Menon, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 1, pp. 23-34
Open Access | Times Cited: 34
Selin Somersan-Karakaya, Eleftherios Mylonakis, Vidya Menon, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 1, pp. 23-34
Open Access | Times Cited: 34
Efficacy and Safety of SARS-CoV-2 Neutralizing Antibody JS016 in Hospitalized Chinese Patients with COVID-19: a Phase 2/3, Multicenter, Randomized, Open-Label, Controlled Trial
Run Dong, Li Jiang, Ting Yang, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 3
Open Access | Times Cited: 8
Run Dong, Li Jiang, Ting Yang, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 3
Open Access | Times Cited: 8
Is SARS‐CoV‐2 viral clearance in nasopharyngeal swabs an appropriate surrogate marker for clinical efficacy of neutralising antibody‐based therapeutics?
Daniele Focosi, Massimo Franchini, Liise‐anne Pirofski, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 5
Daniele Focosi, Massimo Franchini, Liise‐anne Pirofski, et al.
Reviews in Medical Virology (2021) Vol. 32, Iss. 4
Closed Access | Times Cited: 5
